COCH Envoy Medical, Inc.

NASDAQ
$7.10

Envoy Medical, Inc. (COCH) is confirmed to report earnings on November 5, 2026, after the market close. The consensus earnings estimate is a loss of $0.60 per share.

Envoy Medical Beat Consensus Estimates
Thursday, November 5, 2026 · 7:00 AM ET
Earnings Date
4th Quarter, Dec 2026
Nov 5
Thursday · After Close
Earnings Whisper
-
vs ($0.60)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $6.78

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Envoy Medical, Inc.

Envoy Medical Inc. is a medical technology company focused on fully implanted hearing devices. The company's primary device is the fully implanted Acclaim(R) cochlear implant. Envoy Medical Inc., formerly known as Anzu Special Acquisition Corp I, is headquartered in White Bear Lake, Minnesota.

Sector

Healthcare

Industry

Medical Appliances/Equipment

Charts powered in part by Lightweight Charts™ by TradingView.